Kennondale Capital Management »

Akero Therapeutics shares owned by Kennondale Capital Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Kennondale Capital Management from 13F filings

Historical chart of Kennondale Capital Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Kennondale Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Kennondale Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $956k 20k 47.48
2025-06-30 $753k 14k 53.36
2025-03-31 $571k 14k 40.48
2024-12-31 $785k 28k 27.82